An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease
- Gregory M. Chronowski
- , Richard B. Wilder
- , Susan L. Tucker
- , Chul S. Ha
- , Andreas H. Sarris
- , Fredrick B. Hagemeister
- , Ibrahim Barista
- , Mark A. Hess
- , Fernando Cabanillas
- , James D. Cox
Research output: Contribution to journal › Article › peer-review
41
Link opens in a new tab
Scopus
citations